Drug intelligence / Profile preview

NephPlex Rx

Development stage: Unknown
Lead developer: Nephro-Tech
Modality: Small Molecules
Administration: Oral

Overview

NephPlex Rx is a prescription multivitamin and mineral supplement specifically formulated for patients undergoing renal dialysis. It contains a combination of water-soluble B-vitamins (thiamine, riboflavin, niacinamide, pantothenic acid, pyridoxine, biotin, folic acid, and cobalamin), Vitamin C (ascorbic acid), and zinc. These nutrients are often depleted during the dialysis process or restricted due to the dietary limitations required for chronic kidney disease. The supplement is used to prevent or treat nutritional deficiencies in this specific patient population. It is distributed by Biotech Pharmaceuticals in certain regions and labeled/distributed by Nephro-Tech, Inc. in others.

Brand names: NephPlex Rx
Other names: NephPlex Rx multivitamin

Beyond the preview

Go deeper on NephPlex Rx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NephPlex Rx.

Explore the full profile